Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Torre, F

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. [electronic resource] - Clinical and experimental immunology Jun 2004 - 507-12 p. digital

Publication Type: Journal Article

0009-9104

10.1111/j.1365-2249.2004.02476.x doi


Adult
Amantadine--therapeutic use
Antiviral Agents--therapeutic use
Biomarkers--blood
Combined Modality Therapy
Cytokines--metabolism
Enzyme-Linked Immunosorbent Assay--methods
Female
Hepatitis C, Chronic--drug therapy
Humans
Immunotherapy, Active
Interferon-alpha--administration & dosage
Interferon-gamma--blood
Interleukin-10--blood
Interleukin-12--blood
Male
Middle Aged
Receptors, Tumor Necrosis Factor--blood
Ribavirin--therapeutic use
Statistics, Nonparametric
Tumor Necrosis Factor-alpha--metabolism
Viral Load